Aegle Omics – Understanding cancer's molecular makeup is crucial for tailoring effective and precision treatments.

Understanding cancer’s molecular makeup is crucial for tailoring effective and precision treatments. At ‘AEGLE OMICS,’ we utilize cutting-edge technologies for biomarker identification, enabling our medical teams to comprehensively understand tumor biology. With advancements in cancer therapy, oncologists now prioritize molecular profiling to devise personalized treatment strategies. Regardless of tumor location, analyzing its molecular composition provides insights into cancer behavior and guides treatment selection for optimal outcomes.”

Our vision

AEGLE OMICS plays a crucial role in healthcare, providing vital insights into an individual’s genes, disease risks, and treatment options. We assist patients in sending their cancer samples and blood to specialized labs abroad for precise gene testing. By focusing on established gene issues, we streamline testing and reduce unnecessary costs. Additionally, our dedication to affordability ensures that more people can access high-quality genomic testing without compromising accuracy.

Screen for early signs of cancer

30% adults aren’t completing recommended colorectal cancer screenings. A blood test offers a more convenient and efficient alternative to colonoscopy and stool-based testing, which can be unpleasant and time-consuming.” “1 in 3 adults aren’t completing recommended colorectal cancer screenings. A blood test offers a more convenient and efficient alternative to colonoscopy and stool- based testing, which can be unpleasant and time-consuming.”

Tests for patients with early stage cancer

For physicians managing early-stage cancer patients post-surgery, two critical inquiries persist: Is any cancer residual? What’s the risk of recurrence? Our test swiftly and conveniently addresses these queries by detecting minimal residual disease (MRD) from a basic blood sample.

Tests for patients with advanced stage cancer

For physicians caring for patients with advanced cancer, genomic testing offers a comprehensive genomic perspective throughout the treatment process. This enables swift identification of suitable targeted treatments based on individual genomic profiles and facilitates ongoing monitoring of treatment response.

Bio Pharma Solutions

We collaborates with number of biopharmaceutical companies, aiding in expediting the delivery of cutting-edge cancer therapeutics to patients. Our range of innovative solutions and top-tier services encompasses clinical development, commercialization, and real-world evidence, solidifying our commitment to advancing cancer care.

Our mission

Our mission is to provide the most versatile access to genomic testing to our patients and to our medical oncologists, radiation oncologists, hematologists, pathologists, and molecular biologists. We offer the best interpretations, focusing on the most precise pathogenic mutations that represent actionable targets for treatment.